StockData
PDS Biotechnology Corp logo

PDS Biotechnology Corp (PDSB) stock

PDSBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 0/30
$0.89−0.03 (-3.28%)

Close on Nov 17, 2026Market cap $50.03MP/E –Yield –

PDS Biotechnology total assets

Total assets on the balance sheet at the end of each period.

PDS Biotechnology's total assets was $8.81M at Jun 30, 2026. For fiscal 2025 it was $30.49M, down 32.8% from the year before. Over ten years it grew -13.8% a year on average. The highest annual figure on record is $134.09M in fiscal 2015.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$30.49M-32.8%
FY2024Dec 31, 2024$45.36M-23.6%
FY2023Dec 31, 2023$59.39M-22.9%
FY2022Dec 31, 2022$77.01M+14.6%
FY2021Dec 31, 2021$67.20M+117.5%
FY2020Dec 31, 2020$30.89M+113.2%
FY2019Dec 31, 2019$14.49M+8713.0%
FY2018Dec 31, 2018$164.43K-99.8%
FY2017Dec 31, 2017$92.62M-16.5%
FY2016Dec 31, 2016$110.91M-17.3%
FY2015Dec 31, 2015$134.09M+696.0%
FY2014Dec 31, 2014$16.85M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$8.81M-78.2%
Q1 FY2026Mar 31, 2026$24.66M-47.6%
Q4 FY2025Dec 31, 2025$30.49M-32.8%
Q3 FY2025Sep 30, 2025$34.71M-33.8%
Q2 FY2025Jun 30, 2025$40.48M-33.1%
Q1 FY2025Mar 31, 2025$47.03M-31.8%
Q4 FY2024Dec 31, 2024$45.36M-23.6%
Q3 FY2024Sep 30, 2024$52.45M-8.3%
Q2 FY2024Jun 30, 2024$60.50M-5.1%
Q1 FY2024Mar 31, 2024$69.01M+0.8%
Q4 FY2023Dec 31, 2023$59.39M-22.9%
Q3 FY2023Sep 30, 2023$57.19M-23.6%
Q2 FY2023Jun 30, 2023$63.75M+13.8%
Q1 FY2023Mar 31, 2023$68.45M+12.1%
Q4 FY2022Dec 31, 2022$77.01M+14.6%
Q3 FY2022Sep 30, 2022$74.89M+4.4%
Q2 FY2022Jun 30, 2022$56.00M-27.6%
Q1 FY2022Mar 31, 2022$61.04M+119.9%
Q4 FY2021Dec 31, 2021$67.20M+117.5%
Q3 FY2021Sep 30, 2021$71.75M+108.3%
Q2 FY2021Jun 30, 2021$77.39M+285.2%
Q1 FY2021Mar 31, 2021$27.76M+16.0%
Q4 FY2020Dec 31, 2020$30.89M+113.2%
Q3 FY2020Sep 30, 2020$34.45M+77.7%
Q2 FY2020Jun 30, 2020$20.09M-22.1%
Q1 FY2020Mar 31, 2020$23.93M-22.9%
Q4 FY2019Dec 31, 2019$14.49M+8713.0%
Q3 FY2019Sep 30, 2019$19.38M-48.5%
Q2 FY2019Jun 30, 2019$25.80M-45.3%
Q1 FY2019Mar 31, 2019$31.05M-59.5%
Q4 FY2018Dec 31, 2018$164.43K-99.8%
Q3 FY2018Sep 30, 2018$37.67M-62.8%
Q2 FY2018Jun 30, 2018$47.21M-58.2%
Q1 FY2018Mar 31, 2018$76.61M-23.3%
Q4 FY2017Dec 31, 2017$92.62M-16.5%
Q3 FY2017Sep 30, 2017$101.24M-13.2%
Q2 FY2017Jun 30, 2017$112.99M–
Q1 FY2017Mar 31, 2017$99.90M–
Q4 FY2016Dec 31, 2016$110.91M–
Q3 FY2016Sep 30, 2016$116.58M–

More PDS Biotechnology figures

See a number that looks wrong?